Amanda Woodrooffe has 25 years’ experience in drug discovery and in vitro ADME gained from her roles in the biopharma and CRO industries. She has been responsible for operations management and scientific leadership of the UK-based discovery research services business for Asterand / BioIVT since 2010, This business has very recently been acquired by Precision for Medicine, becoming their 2nd European laboratory operation. Prior to this, Amanda held various positions responsible for developing business to business partnerships, pharmaceutical licensing, patent portfolio management and supporting corporate development. Amanda received her PhD from the University of Cambridge.
